Determination of the risk of diabetes mellitus type 2 in the peruvian population. Demographic and family health survey 2022
DOI:
https://doi.org/10.47196/diab.v58i1.727Keywords:
diabetes mellitus type 2, public health, health risk, adult health, surveys and questionnaires, PerúAbstract
Introduction: diabetes mellitus type 2 (DM2) is a disease whose cause involves endogenous and exogenous factors, representing a global public health problem. Prediabetes detection studies through basal glucose levels, applied at the national level, would be highly costly economically and logistically, however, knowing the population at risk is feasible based on anthropometric parameters, health history, and lifestyles, among others, which can be obtained through questionnaires designed to detect the risk of suffering from this endocrinopathy.
Objectives: to analyze the risk of DM2 in the Peruvian population.
Materials and methods: observational, analytical, retrospective and cross-sectional study. The population was around 29,000 non-diabetic adults whose data come from the National Family Health Survey-2022. Bang's diabetes risk questionnaire was used based on the survey data. The variables were: sex, age, body mass index, education level, mean arterial pressure. Pearson's Chi-square test, Cramer's V, student's t, crude Odds Ratio and adjusted by binary logistic regression were performed.
Results: mean body mass index and mean arterial pressure were higher in adults at risk of DM2. The average risk score in men was 4.24 and in women, 2.92. 49% of men were at risk of diabetes and women in 22.30%. 76.30% of adults aged 40 and over were at risk while in young adults it was 9.40%. There was a weak statistically significant association in educational level (V=0.054) and strong in gender (V=0.690). Men were 9.81 times more likely to be at risk than women, and adults 40 years and older were 53.72 times more likely to have DM2 than young adults.
Conclusions: the risk of diabetes is in a high percentage of the Peruvian population mainly associated with sex and age from 40 years, which is accompanied by significant changes in body mass index in women and hypertension in men. The use of the Bang diabetes risk questionnaire, which requires only anthropometric measurements, lifestyle data, personal and family history, would be beneficial for the detection of risk groups at the national level.
References
I. Shetty SS, Kumari S. Los ácidos grasos y su función en la diabetes tipo 2 (Revisión). Exp Ther Med 202;22(1):706. doi: 10.3892/etm.2021.10138.
II. Demant M, Bagger JI, Suppli MP, Lund A, Gyldenløve M, Hansen KB, et al. Determinantes de la hiperglucagonemia en ayunas en pacientes con diabetes tipo 2 y sujetos control no diabéticos. Metab Syndr Relat Disord 2018;16(10):530-6. doi: 10.1089/met.2018.0066.
III. Gembillo G, Ingrasciotta Y, Crisafulli S, Luxi N, Siligato R, Santoro D, et al. Enfermedad renal en pacientes diabéticos: de la fisiopatología a los aspectos farmacológicos con foco en la inercia terapéutica. Int J Mol Sci 2021;22(9):4824. doi: 10.3390/ijms22094824.
IV. Vinik AI, Casellini C, Neumann S. Diabetes and the nervous system. En: Endocrinology Cham: Springer International Publishing 2020:275-353. doi: 10.1007/978-3-030-36694-0_10
V. Shah A, Isath A, Aronow WS. Cardiovascular complications of diabetes. Expert Rev Endocrinol Metab 2022;17(5):383-8.
VI. Lovic D, Piperidou A, Zografou I, Grassos H, Pittaras A, Manolis A. The growing epidemic of diabetes mellitus. Curr Vasc Pharmacol 2020;18(2):104-9.
VII. Pesantes MA, Lazo-Porras M, Cárdenas MK, Diez-Canseco F, Tanaka-Zafra JH, Carrillo-Larco RM, et al. Los retos del cuidado de las personas con diabetes durante el estado de emergencia nacional por la COVID-19 en Lima, Perú: recomendaciones para la atención primaria. Rev Peru Med Exp Salud Publica 2020;37(3):541-6.
VIII. Carrillo-Larco RM, Bernabé-Ortiz A. Diabetes mellitus tipo 2 en Perú: una revisión sistemática sobre la prevalencia e incidencia en población general. Rev Peru Med Exp Salud Publica 2019;36(1):26-36.
IX. Mendo-Vásquez LM, León-Jiménez FE. Frecuencia de prediabetes y factores de riesgo en pobladores de un distrito de La Libertad, Perú 2021. Rev Med Vallejiana 2022;11(2):92-103.
X. Carrillo-Larco RM, Bernabé-Ortiz A. Diabetes mellitus tipo 2 en Perú: una revisión sistemática sobre la prevalencia e incidencia en población general. Rev Peru Med Exp Salud Publica 2019;36(1):26.
XI. Chávez MM, Amemiya-Hoshi I, Suguimoto-Watanabe SP, Arroyo-Aguilar RS, Zeladita-Huaman JA, Castillo-Parra H. Depresión en adultos mayores en el Perú: distribución geoespacial y factores asociados según ENDES 2018 - 2020. An Fac Med 2022;83(3):180-.7.
XII. Bang H. Development and validation of a patient self-assessment score for diabetes risk. Ann Intern Med 2009;151(11):775.
XIII. DeMers D, Wachs D. Physiology, Mean Arterial Pressure. StatPearls Publishing; 2023. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK538226/.
XIV. Foundation Internet Services, LLC. Diabetes risk self assessment. Msdmanuals.com. Disponible en: https://www.msdmanuals.com/medical-calculators/DMSelfAssess-en.htm.
XV. Pajuelo-Ramírez J, Torres-Aparcana L, Agüero-Zamora R, Bernui-Leo I. El sobrepeso, la obesidad y la obesidad abdominal en la población adulta del Perú. An Fac Med 2019;80(1):21-7.
XVI. Holliday CP, Holliday NP, Mulekar M. Women’s perceptions of body mass index. Clin Obes 2019;9(1).
XVII. Philippe TJ, Bao L, Koblanski ME, Viau V. Sex differences in serotonin 5-HT 1A receptor responses to repeated restraint stress in adult male and female rats. Int J Neuropsychopharmacol 2022;25(10):863-76.
XVIII. Songtachalert T, Roomruangwong C, Carvalho AF, Bourin M, Maes M. Anxiety disorders: sex differences in serotonin and tryptophan metabolism. Curr Top Med Chem 2018;18(19):1704-15.
XIX. Amin MR, Pednekar DD, Azgomi HF, van Wietmarschen H, Aschbacher K, Faghih RT. Sparse system identification of leptin dynamics in women with obesity. Front Endocrinol (Lausanne) 2022;13. doi: 10.3389/fendo.2022.769951.
XX. Romero-Giraldo M, Avendaño-Olivares J, Vargas-Fernández R, Runzer-Colmenares FM. Diferencias según sexo en los factores asociados a hipertensión arterial en el Perú. Análisis de la Encuesta Demográfica y de Salud Familiar 2017. An Fac Med 2020;81(1):33-9.
XXI. Song JJ, Ma Z, Wang J, Chen L-X, Zhong J-C. Gender differences in hypertension. J Cardiovasc Transl Res 2020;13(1):47-54.
XXII. Srivaratharajah K, Abramson BL. Hypertension in menopausal women: the effect and role of estrogen. Menopause 2019;26(4):428-30.
XXIII. Zhang J, Crowley SD. Role of T lymphocytes in hypertension. Curr Opin Pharmacol 2015;21:14-9. doi: 10.1016/j.coph.2014.12.003.
XXIV. Nguyen B, Bauman A, Ding D. Association between lifestyle risk factors and incident hypertension among middle-aged and older Australians. Prev Med 2019;118:73-80.
XXV. Yeap BB, Wittert GA. Testosterone, diabetes risk, and diabetes prevention in men. Endocrinol Metab Clin North Am 2022;51(1):157-72.
XXVI. Milionis C, Ilias I, Venaki E, Koukkou E. Glucose homeostasis, diabetes mellitus, and gender-affirming treatment. Biomedicines 2023;11(3):670. doi: 10.3390/biomedicines11030670.
XXVII. Núñez-González S, Delgado-Ron A, Simancas-Racines D. Tendencias y análisis espacio temporal de la mortalidad por diabetes mellitus en Ecuador, 2001-2016. Rev Cub Salud Publica 2020;46(2):e1314.
XXVIII. Borrell LN, Dallo FJ, White K. Education and diabetes in a racially and ethnically diverse population. Am J Public Health 2006;96(9):1637-42. doi: 10.2105/ajph.2005.072884.
XXIX. Tucker LA. Insulin resistance and biological aging: The role of body mass, waist circumference, and inflammation. Biomed Res Int 2022;2022:1-8.
XXX. Mihailidou C, Chatzistamou I, Papavassiliou AG, Kiaris H. Modulation of pancreatic islets’ function and survival during aging involves the differential regulation of endoplasmic reticulum stress by p21 and CHOP. Antioxid Redox Signal 2017;27(4):185-200.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 on behalf of the authors. Reproduction rights: Argentine Diabetes Society
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.
